Back to CS Candriam S.C.A.
AUPH
3 quarters
Position history for CSCandriam S.C.A.'s holdings in Aurinia Pharmaceuticals Inc
No. Candriam S.C.A. exited its AUPH (Aurinia Pharmaceuticals) position in Q3 2019. Its Q2 2019 13F listed 130,000 shares worth $852,000. Candriam S.C.A. already held AUPH in its Q1 2019 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1M
Total Shares Change
-157,500
Quarter-by-Quarter History
Other major holders of AUPH: FMR LLC, BlackRock, Inc.